NTRA (Natera) Beginning Cash Position: $1,088 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NTRA Natera Inc NTRA
77 GF Score
Price $324.84
GF Value $217.87
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Natera Beginning Cash Position?

Natera NTRA -0.07% 77 Beginning Cash Position is $1,088 Mil as of Jun. 2026. GuruFocus rates NTRA with a GF Score™ of 77/100 and a GF Value™ of $217.87 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Natera's Beginning Cash Position for the quarter that ended in Jun. 2026 was $1,088 Mil.

Natera's quarterly Beginning Cash Position increased from Dec. 2025 ($1,041 Mil) to Mar. 2026 ($1,076 Mil) and increased from Mar. 2026 ($1,076 Mil) to Jun. 2026 ($1,088 Mil).

Natera's annual Beginning Cash Position increased from Dec. 2023 ($466 Mil) to Dec. 2024 ($642 Mil) and increased from Dec. 2024 ($642 Mil) to Dec. 2025 ($946 Mil).

Natera Beginning Cash Position Related Terms

Natera Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Natera's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natera Beginning Cash Position Chart

Natera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.86 84.61 466.09 642.10 945.59

Natera Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 973.77 1,000.02 1,041.44 1,076.14 1,087.93
NTRA
77GF Score
Natera Inc NTRA
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Natera Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $1,088 Mil mean?
Natera (NTRA) has a Beginning Cash Position of $1,088 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Natera and its competitors.
Is Natera's Beginning Cash Position too high?
Natera's current Beginning Cash Position is $1,088 Mil. Overall, Natera has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Natera's Beginning Cash Position compare to WAT and A?
Natera's Beginning Cash Position of $1,088 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Natera and its competitors. Natera's current Beginning Cash Position is $1,088 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natera stock overvalued right now?
Based on GuruFocus' analysis, Natera (NTRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $217.87, compared to a current price of $324.84 — trading 49.1% above its estimated fair value. The current Beginning Cash Position is $1,088 Mil. Natera's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Natera (NTRA), the current Beginning Cash Position is $1,088 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Natera (NTRA) Overvalued in 2026?

Based on GuruFocus' analysis, Natera stock appears to be overvalued. The current stock price of $324.84 is trading 49.1% above its estimated GF Value™ of $217.87. GuruFocus considers Natera to be Significantly Overvalued.

Key valuation signals for NTRA:

  • Beginning Cash Position: $1,088 Mil
  • GF Value™: $217.87 vs. price of $324.84 (49.1% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the NTRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Natera Business Description

Other Exchanges NTRA:Mexico45E:Germany
Address 13011 McCallen Pass, Building A Suite 100, Austin, TX, USA, 78753
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
77GF Score

Get the complete analysis for NTRA

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$324.84
Price
$217.87
GF Value